KZR
Kezar Life Sciences Inc
NASDAQ: KZR · HEALTHCARE · BIOTECHNOLOGY
$7.31
+0.14% today
Updated 2026-04-30
Market cap
$53.59M
P/E ratio
—
P/S ratio
6.03x
EPS (TTM)
$-7.66
Dividend yield
—
52W range
$4 – $8
Volume
0.1M
Kezar Life Sciences Inc (KZR) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $7.00M | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — | -100.0% | — |
| Cost of revenue | $154000.00 | $175000.00 | $690000.00 | $1.30M | $1.54M | $1.51M | $1.02M | $1.07M | $1.04M | $897000.00 |
| Gross profit | $-154000.00 | $-175000.00 | $-690000.00 | $-1.30M | $-1.54M | $-1.51M | $-1.02M | $7.00M | $-1.04M | $-897000.00 |
| Gross margin | — | — | — | — | — | — | — | 100.0% | — | — |
| R&D | $7.37M | $6.47M | $18.14M | $27.36M | $30.98M | $38.94M | $51.01M | $85.70M | $65.74M | $33.76M |
| SG&A | $1.62M | $2.28M | $6.59M | $9.98M | $11.97M | $15.72M | $20.15M | $26.54M | $23.39M | $18.51M |
| Operating income | $-8.99M | $-8.75M | $-24.73M | $-37.34M | $-42.95M | $-54.66M | $-71.16M | $-111.42M | $-90.61M | $-52.27M |
| Operating margin | — | — | — | — | — | — | — | -1591.8% | — | — |
| EBITDA | $-8.84M | $-8.34M | $-24.04M | $-36.04M | $-41.41M | $-52.96M | $-70.14M | $-99.25M | $-81.10M | $-51.37M |
| EBITDA margin | — | — | — | — | — | — | — | -1417.9% | — | — |
| EBIT | $-8.99M | $-8.52M | $-24.73M | $-37.34M | $-42.95M | $-54.47M | $-71.16M | $-100.32M | $-82.14M | $-52.27M |
| Interest expense | $0.00 | $0.00 | $0.00 | $0.00 | $1.21M | $159000.00 | $1.19M | $1.55M | $1.59M | $1.37M |
| Income tax | $0.00 | $0.00 | $1.56M | $-3.56M | $-2.75M | $-1.35M | $-2.92M | $898105.00 | — | — |
| Effective tax rate | 0.0% | 0.0% | -7.2% | 10.1% | 6.6% | 2.4% | 4.3% | -0.9% | 0.0% | 0.0% |
| Net income | $-8.99M | $-8.52M | $-23.17M | $-31.53M | $-38.99M | $-54.63M | $-65.32M | $-101.87M | $-83.74M | $-56.03M |
| Net income growth (YoY) | — | +5.3% | -172.0% | -36.1% | -23.7% | -40.1% | -19.6% | -56.0% | +17.8% | +33.1% |
| Profit margin | — | — | — | — | — | — | — | -1455.3% | — | — |